| 1 |
Alprostadil FDA Label
|
| 2 |
Bosentan FDA Label
|
| 3 |
Carvedilol FDA Label
|
| 4 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1915).
|
| 5 |
Hydroxyurea FDA Label
|
| 6 |
Iloprost FDA Label
|
| 7 |
Imatinib FDA Label
|
| 8 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 9 |
2007 FDA drug approvals: a year of flux. Nat Rev Drug Discov. 2008 Feb;7(2):107-9.
|
| 10 |
Nitric Oxide FDA Label
|
| 11 |
Tadalafil FDA Label
|
| 12 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7310).
|
| 13 |
Treprostinil FDA Label
|
| 14 |
Warfarin FDA Label
|
| 15 |
ClinicalTrials.gov (NCT03431649) Efficacy of Beraprost in Lowering Pulmonary Arterial Pressure in Children. U.S. National Institutes of Health.
|
| 16 |
Pfizer. Product Development Pipeline. March 31 2009.
|
| 17 |
ClinicalTrials.gov (NCT02216279) Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension. U.S. National Institutes of Health.
|
| 18 |
ClinicalTrials.gov (NCT05737940) A Phase IIb Randomised, Double-blind, Placebo-controlled, Multi-centre, Dose-ranging Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Due to Left Heart Disease (WHO Group 2). U.S.National Institutes of Health.
|
| 19 |
ClinicalTrials.gov (NCT02279745) Long Term Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension. U.S. National Institutes of Health.
|
| 20 |
A Phase I study of the transplantation of genetically marked autologous bone marrow stromal cells. Hum Gene Ther. 1998 Mar 1;9(4):591-600.
|
| 21 |
ClinicalTrials.gov (NCT01083524) Dichloroacetate (DCA) for the Treatment of Pulmonary Arterial Hypertension. U.S. National Institutes of Health.
|
| 22 |
The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
|
| 23 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 345).
|
| 24 |
Downregulation of Forkhead box F1 gene expression in the pulmonary vasculature of nitrofen-induced congenital diaphragmatic hernia.Pediatr Surg Int. 2016 Dec;32(12):1121-1126. doi: 10.1007/s00383-016-3967-1. Epub 2016 Sep 23.
|
| 25 |
The Role of Activin Receptor-Like Kinase 1 Signaling in the Pulmonary Vasculature of Experimental Diaphragmatic Hernia.Eur J Pediatr Surg. 2016 Feb;26(1):106-11. doi: 10.1055/s-0035-1566105. Epub 2015 Nov 5.
|
| 26 |
Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats.Eur Rev Med Pharmacol Sci. 2011 Jan;15(1):1-7.
|
| 27 |
Increased pulmonary heme oxygenase-1 and delta-aminolevulinate synthase expression in monocrotaline-induced pulmonary hypertension.Curr Neurovasc Res. 2005 Apr;2(2):133-9. doi: 10.2174/1567202053586794.
|
| 28 |
Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.Circulation. 2019 Oct 22;140(17):1409-1425. doi: 10.1161/CIRCULATIONAHA.119.040629. Epub 2019 Aug 29.
|
| 29 |
Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.J Clin Invest. 1996 Jun 1;97(11):2491-8. doi: 10.1172/JCI118696.
|
| 30 |
Downregulation of angiopoietin-1 and Tie2 in chronic hypoxic pulmonary hypertension.Respiration. 2008;75(3):328-38. doi: 10.1159/000112432. Epub 2007 Dec 10.
|
| 31 |
Temporal changes of angiopoietins and Tie2 expression in rat lungs after monocrotaline-induced pulmonary hypertension.Comp Med. 2009 Aug;59(4):350-6.
|
| 32 |
Resveratrol prevents hypoxia-induced arginase II expression and proliferation of human pulmonary artery smooth muscle cells via Akt-dependent signaling.Am J Physiol Lung Cell Mol Physiol. 2014 Aug 15;307(4):L317-25. doi: 10.1152/ajplung.00285.2013. Epub 2014 Jun 20.
|
| 33 |
Rats with Chronic, Stable Pulmonary Hypertension Tolerate Low Dose Sevoflurane Inhalation as Well as Normal Rats Do.PLoS One. 2016 May 4;11(5):e0154154. doi: 10.1371/journal.pone.0154154. eCollection 2016.
|
| 34 |
Erythropoietin, but not asialoerythropoietin or carbamyl-erythropoietin, attenuates monocrotaline-induced pulmonary hypertension in rats.Clin Exp Hypertens. 2012;34(8):575-81. doi: 10.3109/10641963.2012.681728. Epub 2012 May 4.
|
| 35 |
Treatment of severe pulmonary hypertension: a bradykinin receptor 2 agonist B9972 causes reduction of pulmonary artery pressure and right ventricular hypertrophy.Peptides. 2005 Aug;26(8):1292-300. doi: 10.1016/j.peptides.2005.03.050.
|
| 36 |
Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.J Clin Invest. 2005 Jun;115(6):1479-91. doi: 10.1172/JCI23203.
|
| 37 |
Modification of hemodynamic and immune responses to exposure with a weak antigen by the expression of a hypomorphic BMPR2 gene.PLoS One. 2013;8(1):e55180. doi: 10.1371/journal.pone.0055180. Epub 2013 Jan 29.
|
| 38 |
Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension.Circ Res. 2015 Aug 28;117(6):525-35. doi: 10.1161/CIRCRESAHA.115.307004. Epub 2015 Jul 29.
|
| 39 |
Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.Am J Pathol. 2010 Mar;176(3):1130-8. doi: 10.2353/ajpath.2010.090832. Epub 2010 Jan 28.
|
| 40 |
CGRP and somatostatin modulate chronic hypoxic pulmonary hypertension.Am J Physiol. 1992 Sep;263(3 Pt 2):H681-90. doi: 10.1152/ajpheart.1992.263.3.H681.
|
| 41 |
Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.Circ Res. 2012 Aug 3;111(4):469-81. doi: 10.1161/CIRCRESAHA.112.266361. Epub 2012 Jun 22.
|
| 42 |
Ruscogenin attenuates monocrotaline-induced pulmonary hypertension in rats.Int Immunopharmacol. 2013 May;16(1):7-16. doi: 10.1016/j.intimp.2013.03.010. Epub 2013 Mar 26.
|
| 43 |
Prenatal treatment with rosiglitazone attenuates vascular remodeling and pulmonary monocyte influx in experimental congenital diaphragmatic hernia.PLoS One. 2018 Nov 12;13(11):e0206975. doi: 10.1371/journal.pone.0206975. eCollection 2018.
|
| 44 |
Endogenous hydrogen sulfide regulates pulmonary artery collagen remodeling in rats with high pulmonary blood flow.Exp Biol Med (Maywood). 2009 May;234(5):504-12. doi: 10.3181/0807-RM-230. Epub 2009 Feb 20.
|
| 45 |
Interruption of CD40 Pathway Improves Efficacy of Transplanted Endothelial Progenitor Cells in Monocrotaline Induced Pulmonary Arterial Hypertension.Cell Physiol Biochem. 2015;36(2):683-96. doi: 10.1159/000430130.
|
| 46 |
Activation of PPAR- ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21(WAF1): an in vivo study in rats.Life Sci. 2014 Mar 7;98(1):39-43. doi: 10.1016/j.lfs.2013.12.208. Epub 2014 Jan 8.
|
| 47 |
17-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects.Am J Respir Crit Care Med. 2012 May 1;185(9):965-80. doi: 10.1164/rccm.201107-1293OC. Epub 2012 Mar 1.
|
| 48 |
Secretory clusterin is upregulated in rats with pulmonary arterial hypertension induced by systemic-to-pulmonary shunts and exerts important roles in pulmonary artery smooth muscle cells.Acta Physiol (Oxf). 2015 Feb;213(2):505-18. doi: 10.1111/apha.12352. Epub 2014 Aug 25.
|
| 49 |
[The change of fractalkine in lung tissue of rat with hypoxic pulmonary hypertension].Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Mar;39(2):227-30.
|
| 50 |
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension.Eur Respir J. 2007 May;29(5):937-43. doi: 10.1183/09031936.00104706. Epub 2006 Dec 20.
|
| 51 |
Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat.Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2659-68. doi: 10.1152/ajpheart.00953.2007. Epub 2008 Apr 18.
|
| 52 |
[Preventive effects of montelukast on hypoxic pulmonary hypertension in rats].Sichuan Da Xue Xue Bao Yi Xue Ban. 2003 Jul;34(3):555-8.
|
| 53 |
[Chronic theatment with an endothelin-converting enzyme inhibitor reduces the development of hypoxia-induced pulmonary hypertension in rat].Ross Fiziol Zh Im I M Sechenova. 2008 Jul;94(7):777-84.
|
| 54 |
Correlation of plasma endothelin-1 levels with pulmonary hypertension after inhaled nitric oxide therapy.J Ayub Med Coll Abbottabad. 2009 Jul-Sep;21(3):106-10.
|
| 55 |
Inhibition of endothelin-1 and hypoxia-induced pulmonary pressor responses in the rat by a novel selective endothelin-A receptor antagonist, di-n-butylaminocarbamyl-L-leucyl-D-tryptophanyl-D-4-chloro-Phe.J Cardiovasc Pharmacol. 2010 Sep;56(3):246-54. doi: 10.1097/FJC.0b013e3181e89f36.
|
| 56 |
Endotoxin causes pulmonary hypertension by upregulating smooth muscle endothelin type-B receptors: role of aldose reductase.Shock. 2008 Aug;30(2):189-96. doi: 10.1097/shk.0b013e318160f03b.
|
| 57 |
Egr-1 expression during neointimal development in flow-associated pulmonary hypertension.Am J Pathol. 2011 Nov;179(5):2199-209. doi: 10.1016/j.ajpath.2011.07.030. Epub 2011 Sep 13.
|
| 58 |
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension. Nat Genet. 2014 Jan;46(1):65-9. doi: 10.1038/ng.2844. Epub 2013 Dec 1.
|
| 59 |
Differential expression of three hypoxia-inducible factor-alpha subunits in pulmonary arteries of rat with hypoxia-induced hypertension.Acta Biochim Biophys Sin (Shanghai). 2005 Oct;37(10):665-72. doi: 10.1111/j.1745-7270.2005.00095.x.
|
| 60 |
Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats.J Hypertens. 2009 Feb;27(2):322-31. doi: 10.1097/hjh.0b013e32831aedfa.
|
| 61 |
Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents.J Clin Invest. 2009 Mar;119(3):512-23. doi: 10.1172/JCI35070. Epub 2009 Feb 9.
|
| 62 |
Pulmonary hypertension-induced GATA4 activation in the right ventricle.Hypertension. 2010 Dec;56(6):1145-51. doi: 10.1161/HYPERTENSIONAHA.110.160515. Epub 2010 Nov 8.
|
| 63 |
Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy.Mol Genet Metab. 2002 Sep-Oct;77(1-2):91-8. doi: 10.1016/s1096-7192(02)00122-1.
|
| 64 |
Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report.BMC Pulm Med. 2016 Jan 22;16:17. doi: 10.1186/s12890-016-0183-7.
|
| 65 |
Sildenafil improves long-term effect of endothelial progenitor cell-based treatment for monocrotaline-induced rat pulmonary arterial hypertension.Cytotherapy. 2013 Feb;15(2):209-23. doi: 10.1016/j.jcyt.2012.09.002. Epub 2012 Dec 11.
|
| 66 |
Expression of adrenomedullin and its receptor in lungs of rats with hypoxic pulmonary hypertension.Chin Med J (Engl). 2002 Dec;115(12):1806-8.
|
| 67 |
Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.Circulation. 2012 Jul 24;126(4):455-67. doi: 10.1161/CIRCULATIONAHA.112.103176. Epub 2012 Jun 18.
|
| 68 |
HMGB1 promotes the development of pulmonary arterial hypertension in rats.PLoS One. 2014 Jul 17;9(7):e102482. doi: 10.1371/journal.pone.0102482. eCollection 2014.
|
| 69 |
Attenuation of chronic hypoxic pulmonary hypertension by simvastatin.Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H938-45. doi: 10.1152/ajpheart.01097.2002. Epub 2003 May 15.
|
| 70 |
Serotonin 5-HT(2B) receptor loss of function mutation in a patient with fenfluramine-associated primary pulmonary hypertension. Cardiovasc Res. 2003 Dec 1;60(3):518-28. doi: 10.1016/j.cardiores.2003.09.015.
|
| 71 |
Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo. Circ Res. 2010 Jul 23;107(2):252-62. doi: 10.1161/CIRCRESAHA.109.209940. Epub 2010 Jun 3.
|
| 72 |
Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations.Arthritis Res Ther. 2009;11(5):R147. doi: 10.1186/ar2821. Epub 2009 Oct 2.
|
| 73 |
Imbalance of NFATc2 and KV1.5 Expression in Rat Pulmonary Vasculature of Nitrofen-Induced Congenital Diaphragmatic Hernia.Eur J Pediatr Surg. 2017 Feb;27(1):68-73. doi: 10.1055/s-0036-1587589. Epub 2016 Aug 14.
|
| 74 |
Characterization and regulation of wild-type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension. J Physiol. 2019 Feb;597(4):1087-1101. doi: 10.1113/JP277275. Epub 2018 Nov 24.
|
| 75 |
BK channels in rat and human pulmonary smooth muscle cells are BK-(1) functional complexes lacking the oxygen-sensitive stress axis regulated exon insert. Pulm Circ. 2016 Dec;6(4):563-575. doi: 10.1086/688838.
|
| 76 |
Elevated pulmonary arterial pressure in Zucker diabetic fatty rats.PLoS One. 2019 Jan 28;14(1):e0211281. doi: 10.1371/journal.pone.0211281. eCollection 2019.
|
| 77 |
Upregulated copper transporters in hypoxia-induced pulmonary hypertension. PLoS One. 2014 Mar 10;9(3):e90544. doi: 10.1371/journal.pone.0090544. eCollection 2014.
|
| 78 |
Simvastatin attenuates pulmonary vascular remodelling by down-regulating matrix metalloproteinase-1 and -9 expression in a carotid artery-jugular vein shunt pulmonary hypertension model in rats.Eur J Cardiothorac Surg. 2012 Nov;42(5):e121-7. doi: 10.1093/ejcts/ezs445.
|
| 79 |
Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension.Am J Respir Cell Mol Biol. 2013 May;48(5):568-77. doi: 10.1165/rcmb.2012-0429OC.
|
| 80 |
Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and Is a Therapeutic Target in Pulmonary Arterial Hypertension.Circulation. 2017 Apr 18;135(16):1532-1546. doi: 10.1161/CIRCULATIONAHA.116.024557. Epub 2017 Feb 15.
|
| 81 |
Tetrahydrobiopterin (BH(4) ): Targeting endothelial nitric oxide synthase as a potential therapy for pulmonary hypertension.Cardiovasc Ther. 2018 Feb;36(1). doi: 10.1111/1755-5922.12312. Epub 2017 Dec 3.
|
| 82 |
Attenuated vasodilatation in lambs with endogenous and exogenous activation of cGMP signaling: role of protein kinase G nitration.J Cell Physiol. 2011 Dec;226(12):3104-13. doi: 10.1002/jcp.22692.
|
| 83 |
Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.Br J Pharmacol. 2002 Dec;137(8):1187-94. doi: 10.1038/sj.bjp.0704984.
|
| 84 |
Tadalafil, a long-acting inhibitor of PDE5, improves pulmonary hemodynamics and survival rate of monocrotaline-induced pulmonary artery hypertension in rats.J Pharmacol Sci. 2009 Nov;111(3):235-43. doi: 10.1254/jphs.09110fp. Epub 2009 Oct 31.
|
| 85 |
Increased expression of PDGF A- and B-chain genes in rat lungs with hypoxic pulmonary hypertension.Am J Physiol. 1993 Feb;264(2 Pt 1):L100-6. doi: 10.1152/ajplung.1993.264.2.L100.
|
| 86 |
Hypoxia-inducible factor-1 /platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling.Respir Res. 2011 Aug 5;12(1):103. doi: 10.1186/1465-9921-12-103.
|
| 87 |
Repeated gene transfer of naked prostacyclin synthase plasmid into skeletal muscles attenuates monocrotaline-induced pulmonary hypertension and prolongs survival in rats.Hum Gene Ther. 2004 Dec;15(12):1270-8. doi: 10.1089/hum.2004.15.1270.
|
| 88 |
Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation.J Cardiovasc Pharmacol. 2007 Dec;50(6):697-702. doi: 10.1097/FJC.0b013e3181593774.
|
| 89 |
Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity.Am J Physiol. 1991 Dec;261(6 Pt 2):H1716-26. doi: 10.1152/ajpheart.1991.261.6.H1716.
|
| 90 |
A Selective Transforming Growth Factor- Ligand Trap Attenuates Pulmonary Hypertension.Am J Respir Crit Care Med. 2016 Nov 1;194(9):1140-1151. doi: 10.1164/rccm.201510-1955OC.
|
| 91 |
Upregulation of GLUT-4 in right ventricle of rats with monocrotaline-induced pulmonary hypertension.Med Sci Monit. 2008 Dec;14(12):BR261-4.
|
| 92 |
Continuous fluoxetine administration prevents recurrence of pulmonary arterial hypertension and prolongs survival in rats.Clin Exp Pharmacol Physiol. 2009 Aug;36(8):e1-5. doi: 10.1111/j.1440-1681.2009.05181.x. Epub 2009 Mar 26.
|
| 93 |
Smad signaling in the rat model of monocrotaline pulmonary hypertension.Toxicol Pathol. 2008 Feb;36(2):311-20. doi: 10.1177/0192623307311402. Epub 2008 Mar 26.
|
| 94 |
Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension.Arterioscler Thromb Vasc Biol. 2007 May;27(5):1072-8. doi: 10.1161/ATVBAHA.107.141200. Epub 2007 Mar 8.
|
| 95 |
Tachykinin dysfunction attenuates monocrotaline-induced pulmonary hypertension.Toxicol Appl Pharmacol. 2003 Mar 15;187(3):178-85. doi: 10.1016/s0041-008x(02)00070-4.
|
| 96 |
Positive feedback-loop of telomerase reverse transcriptase and 15-lipoxygenase-2 promotes pulmonary hypertension.PLoS One. 2013 Dec 23;8(12):e83132. doi: 10.1371/journal.pone.0083132. eCollection 2013.
|
| 97 |
EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis.Am J Physiol Lung Cell Mol Physiol. 2008 Jun;294(6):L1217-25. doi: 10.1152/ajplung.00020.2008. Epub 2008 Apr 18.
|
| 98 |
Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension.Am J Respir Crit Care Med. 2008 Apr 15;177(8):896-905. doi: 10.1164/rccm.200707-1083OC. Epub 2008 Jan 17.
|
| 99 |
The transforming growth factor-beta/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension.Eur Respir J. 2007 Jun;29(6):1094-104. doi: 10.1183/09031936.00138206. Epub 2007 Mar 28.
|
| 100 |
Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension.Basic Res Cardiol. 2009 Sep;104(5):535-45. doi: 10.1007/s00395-009-0017-3. Epub 2009 Mar 14.
|
| 101 |
Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice.Circulation. 2008 Jun 3;117(22):2928-37. doi: 10.1161/CIRCULATIONAHA.108.767558. Epub 2008 May 27.
|
| 102 |
Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension.Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13861-6. doi: 10.1073/pnas.0405908101. Epub 2004 Sep 9.
|
| 103 |
Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells.Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):519-25. doi: 10.1161/01.ATV.0000154279.98244.eb. Epub 2004 Dec 23.
|
| 104 |
A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats.Chest. 2007 Oct;132(4):1265-74. doi: 10.1378/chest.06-2243.
|
| 105 |
Pharmacogenomics in pulmonary arterial hypertension: Toward a mechanistic, target-based approach to therapy.Pulm Circ. 2011 Jul-Sep;1(3):383-8. doi: 10.4103/2045-8932.87306.
|
| 106 |
ABCA3 mutations led to pulmonary fibrosis and emphysema with pulmonary hypertension in an 8-year-old girl.Pediatr Pulmonol. 2016 Jun;51(6):E21-3. doi: 10.1002/ppul.23379. Epub 2016 Jan 18.
|
| 107 |
Role of the Aryl Hydrocarbon Receptor in Sugen 5416-induced Experimental Pulmonary Hypertension.Am J Respir Cell Mol Biol. 2018 Mar;58(3):320-330. doi: 10.1165/rcmb.2017-0260OC.
|
| 108 |
Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat.Circ Res. 2015 May 8;116(10):1680-90. doi: 10.1161/CIRCRESAHA.116.305265. Epub 2015 Mar 12.
|
| 109 |
Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension. Nat Genet. 2013 May;45(5):518-21. doi: 10.1038/ng.2581. Epub 2013 Mar 17.
|
| 110 |
Genetic polymorphisms of angiotensin system genes in congenital diaphragmatic hernia associated with persistent pulmonary hypertension.J Pediatr Surg. 2004 Mar;39(3):302-6; discussion 302-6. doi: 10.1016/j.jpedsurg.2003.11.008.
|
| 111 |
Rac regulates thrombin-induced tissue factor expression in pulmonary artery smooth muscle cells involving the nuclear factor-kappaB pathway.Antioxid Redox Signal. 2004 Aug;6(4):713-20. doi: 10.1089/1523086041361703.
|
| 112 |
Mesenchymal stem cells restore lung function by recruiting resident and nonresident proteins.Cell Transplant. 2011;20(10):1561-74. doi: 10.3727/096368910X557254. Epub 2011 Mar 7.
|
| 113 |
Lung-specific RNA interference of coupling factor 6, a novel peptide, attenuates pulmonary arterial hypertension in rats.Respir Res. 2016 Aug 4;17(1):99. doi: 10.1186/s12931-016-0409-5.
|
| 114 |
Characterization of the bone morphogenetic protein (BMP) system in human pulmonary arterial smooth muscle cells isolated from a sporadic case of primary pulmonary hypertension: roles of BMP type IB receptor (activin receptor-like kinase-6) in the mitotic action.Endocrinology. 2004 Sep;145(9):4344-54. doi: 10.1210/en.2004-0234. Epub 2004 Jun 10.
|
| 115 |
Elevated pulmonary arterial pressure and altered expression of Ddah1 and Arg1 in mice lacking cavin-1/PTRF.Physiol Rep. 2013 Jun;1(1):e00008. doi: 10.1002/PHY2.8. Epub 2013 Jun 7.
|
| 116 |
Resveratrol downregulates acute pulmonary thromboembolism-induced pulmonary artery hypertension via p38 mitogen-activated protein kinase and monocyte chemoattractant protein-1 signaling in rats.Life Sci. 2012 May 22;90(19-20):721-7. doi: 10.1016/j.lfs.2012.03.008. Epub 2012 Apr 1.
|
| 117 |
Effects of angiotensin II intervention on MMP-2, MMP-9, TIMP-1, and collagen expression in rats with pulmonary hypertension.Genet Mol Res. 2015 Mar 6;14(1):1707-17. doi: 10.4238/2015.March.6.17.
|
| 118 |
Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa.Hum Mol Genet. 2002 Sep 1;11(18):2113-8. doi: 10.1093/hmg/11.18.2113.
|
| 119 |
Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension.Eur Respir J. 2008 Apr;31(4):736-41. doi: 10.1183/09031936.00055107. Epub 2007 Dec 5.
|
| 120 |
Simvastatin restores down-regulated GATA-6 expression in pulmonary hypertensive rats.Exp Lung Res. 2009 Jun;35(5):411-26. doi: 10.1080/01902140902736819.
|
| 121 |
The enzymatic degradation of hyaluronan is associated with disease progression in experimental pulmonary hypertension.Am J Physiol Lung Cell Mol Physiol. 2010 Feb;298(2):L148-57. doi: 10.1152/ajplung.00097.2009. Epub 2009 Nov 13.
|
| 122 |
MicroRNA-140 is elevated and mitofusin-1 is downregulated in the right ventricle of the Sugen5416/hypoxia/normoxia model of pulmonary arterial hypertension.Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H689-98. doi: 10.1152/ajpheart.00264.2016. Epub 2016 Jul 15.
|
| 123 |
Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia.J Clin Invest. 1990 Jan;85(1):115-20. doi: 10.1172/JCI114400.
|
| 124 |
Proteomic analysis of the lung in rats with hypobaric hypoxia-induced pulmonary hypertension.Histol Histopathol. 2013 Jul;28(7):893-902. doi: 10.14670/HH-28.893. Epub 2013 Jan 10.
|
| 125 |
[Changes of intermedin/adrenomedullin 2 and its receptors in the right ventricle of rats with chronic hypoxic pulmonary hypertension].Sheng Li Xue Bao. 2007 Apr 25;59(2):210-4.
|
| 126 |
Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction.Cardiovasc Res. 2009 May 1;82(2):296-302. doi: 10.1093/cvr/cvn349. Epub 2008 Dec 16.
|
|
|
|
|
|
|
